Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4)

被引:26
|
作者
Bookhout, Christine [1 ]
Bouldin, Thomas W. [1 ]
Ellison, David W. [2 ]
机构
[1] Univ N Carolina, Dept Surg Pathol, Chapel Hill, NC 27599 USA
[2] St Jude Childrens Res Hosp, Dept Neuropathol, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
atypical teratoid; rhabdoid tumor; BRG1; INI1; SMARCA4; SMARCB1; CENTRAL-NERVOUS-SYSTEM; MALIGNANT RHABDOID TUMOR; SMALL-CELL-CARCINOMA; PREDISPOSITION SYNDROME; HYPERCALCEMIC TYPE; HSNF5/INI1; MUTATIONS; GERMLINE; CLASSIFICATION; PROGNOSIS;
D O I
10.1111/neup.12452
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, highly aggressive malignancy of the central nervous system (CNS) usually diagnosed in infancy or childhood, most often characterized by loss of expression of the SMARCB1 gene product integrase interactor 1 (INI1) protein. We report a case of AT/RT in a 3month old boy with retained expression of INI1 by immunohistochemistry. Additional testing demonstrated loss of expression of the SMARCA4 gene product Brahma-related gene 1 (BRG1) protein by immunohistochemistry, confirmed by next generation sequencing showing a nonsense mutation in SMARCA4. This case illustrates that positivity for INI1 does not rule out a diagnosis of AT/RT, and additional testing, including BRG1/SMARCA4 analysis, is warranted in cases where clinical suspicion is high.
引用
收藏
页码:305 / 308
页数:4
相关论文
共 50 条
  • [41] SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†
    Abedini, Atefeh
    Landry, David A.
    Macaulay, Angus D.
    Vaishnev, Het
    Parbhakar, Ashna
    Ibrahim, Dalia
    Salehi, Reza
    Maranda, Vincent
    Macdonald, Elizabeth
    Vanderhyden, Barbara C.
    BIOLOGY OF REPRODUCTION, 2023, 108 (02) : 279 - 291
  • [42] Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth
    Kim, Kimberly H.
    Roberts, Charles W. M.
    CANCER GENETICS, 2014, 207 (09) : 365 - 372
  • [43] Detection of SMARCB1 Loss in Ascites Cells in the Diagnosis of an Abdominal Rhabdoid Tumor
    Kerl, Kornelius
    Oyen, Florian
    Leuschner, Ivo
    Schneppenheim, Reinhard
    Nagel, Inga
    Siebert, Reiner
    Groll, Andreas H.
    Hartmann, Wolfgang
    Barth, Peter Josef
    Bartelheim, Kerstin
    Seringer, Angela
    Wardelmann, Eva
    Fruehwald, Michael C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (05) : 897 - 900
  • [44] TLE1 Expression in Malignant Rhabdoid Tumor and Atypical Teratoid/Rhabdoid Tumor
    Duncan, Virginia E.
    Wicker, Jason A.
    Kelly, David R.
    Li, Rong
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2018, 21 (06) : 522 - 527
  • [45] SMARCB1 (INI1) Deficient Sinonasal Carcinoma With Yolk Sac Tumor Differentiation: Case Report and Review of the Literature
    Gradecki, Sarah E.
    Kelting, Sarah M.
    Stelow, Edward B.
    AJSP-REVIEWS AND REPORTS, 2021, 26 (04): : 259 - 263
  • [46] SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond Evolving concepts
    Agaimy, Abbas
    Hartmann, Arndt
    PATHOLOGE, 2021, 42 (06): : 571 - 577
  • [47] Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis
    Meng, Xiangpeng
    Ma, Jia
    Meng, Nan
    Yun, Tianyu
    Niu, Beifang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas
    Ahadi, Mahsa S.
    Fuchs, Talia L.
    Clarkson, Adele
    Sheen, Amy
    Sioson, Loretta
    Chou, Angela
    Gill, Anthony J.
    HISTOPATHOLOGY, 2022, 80 (06) : 906 - 921
  • [49] SMARCB1/INI1 Genetic Inactivation Is Responsible for Tumorigenic Properties of Epithelioid Sarcoma Cell Line VAESBJ
    Brenca, Monica
    Rossi, Sabrina
    Lorenzetto, Erica
    Piccinin, Elena
    Piccinin, Sara
    Rossi, Francesca Maria
    Giuliano, Alberto
    Tos, Angelo Paolo Dei
    Maestro, Roberta
    Modena, Piergiorgio
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (06) : 1060 - 1072
  • [50] Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation
    Ammerlaan, A. C. J.
    Houben, M. P. W. A.
    Tijssen, C. C.
    Wesseling, P.
    Hulsebos, T. J. M.
    CHILDS NERVOUS SYSTEM, 2008, 24 (07) : 855 - 857